These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2086467)

  • 1. Postural variation of exophthalmometry in Graves' ophthalmopathy.
    Asad R; Tewari HK; Ahuja MM; Mithal A
    Indian J Ophthalmol; 1990; 38(4):166-8. PubMed ID: 2086467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of exophthalmos measurement and the exophthalmometry value distribution in a healthy Dutch population and in Graves' patients. An exploratory study.
    Mourits MP; Lombardo SH; van der Sluijs FA; Fenton S
    Orbit; 2004 Sep; 23(3):161-8. PubMed ID: 15545129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positional effects on exophthalmometer readings in Graves' eye disease.
    Frueh BR; Garber F; Grill R; Musch DC
    Arch Ophthalmol; 1985 Sep; 103(9):1355-6. PubMed ID: 3840014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese.
    Kamizono S; Hiromatsu Y; Seki N; Bednarczuk T; Matsumoto H; Kimura A; Itoh K
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):759-64. PubMed ID: 10848881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma leptin concentrations in patients with Graves' disease with or without ophthalmopathy.
    Ozata M; Uckaya G; Bolu E; Corapcioglu D; Bingol N; Ozdemir IC
    Med Sci Monit; 2001; 7(4):696-700. PubMed ID: 11433197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy.
    Wakelkamp IM; Prummel MF; Wiersinga WM
    Horm Metab Res; 2004 Jan; 36(1):44-7. PubMed ID: 14983406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of HLA antigen BW35 with severe Graves' ophthalmopathy.
    Sergott RC; Felberg NT; Savino PJ; Blizzard JJ; Schatz NJ; Sanford CA
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):124-7. PubMed ID: 6600737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients.
    Esteghamati A; Khalilzadeh O; Mobarra Z; Anvari M; Tahvildari M; Amiri HM; Rashidi A; Solgi G; Parivar K; Nikbin B; Amirzargar A
    Eur J Intern Med; 2009 Jul; 20(4):424-8. PubMed ID: 19524188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exophthalmometer readings in patients with Graves' eye disease.
    Frueh BR; Musch DC; Garber FW
    Ophthalmic Surg; 1986 Jan; 17(1):37-40. PubMed ID: 3754041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detectable serum IgE levels in Graves' ophthalmopathy.
    Molnár I; Horváth S; Balázs C
    Eur J Med Res; 1996 Sep; 1(11):543-6. PubMed ID: 9438158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of urinary mucopolysaccharides in Graves' disease.
    Ursu H; Dumitrescu C; Bartoc R; Dumitriu L
    Endocrinologie; 1984; 22(4):277-82. PubMed ID: 6240765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
    Molnár I
    Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioiodine therapy and Graves' ophthalmopathy.
    Sisson JC; Schipper MJ; Nelson CC; Freitas JE; Frueh BR
    J Nucl Med; 2008 Jun; 49(6):923-30. PubMed ID: 18483104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral parameters of oxidative stress in patients with infiltrative Graves' ophthalmopathy treated with corticosteroids.
    Bednarek J; Wysocki H; Sowiński J
    Immunol Lett; 2004 May; 93(2-3):227-32. PubMed ID: 15158621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Graves' ophthalmopathy--a prospective clinical study].
    Bogdănici C; Marcu C
    Oftalmologia; 1999; 48(3):19-22, 25. PubMed ID: 10641113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic evaluation of Graves' ophthalmopathy.
    Bahn RS; Garrity JA; Bartley GB; Gorman CA
    Endocrinol Metab Clin North Am; 1988 Sep; 17(3):527-45. PubMed ID: 3065079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graves' ophthalmopathy.
    Bistriceanu M; Cergă A; Lichiardopol-Răducanu C
    Oftalmologia; 1993; 37(2):99-103. PubMed ID: 8507632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
    de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy.
    Bradley EA; Sloan JA; Novotny PJ; Garrity JA; Woog JJ; West SK
    Ophthalmology; 2006 Aug; 113(8):1450-4. PubMed ID: 16769116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical staining of normal and Graves' extraocular muscle.
    Tallstedt L; Norberg R
    Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):175-84. PubMed ID: 2448263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.